secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001193125-22-291639
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters Corp appoints Dan Brennan and Mark Vergnano to Board of Directors
------------------------------------------------------------------------

- Board expanded from 7 to 9 members; appointments effective November 23, 2022.
- Brennan is EVP & CFO of Boston Scientific; Vergnano is former Chairman, President & CEO of Chemours.
- Each receives initial equity grant valued at $36,666 (50% RSU, 50% NSO) vesting in one year, plus prorated cash retainer of $7,418.
- Both deemed independent under NYSE standards; board now 8 of 9 independent, 5 appointed in last 5 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312522291639/0001193125-22-291639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312522291639/d416781d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-291639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer